Viewing Study NCT03144856


Ignite Creation Date: 2025-12-24 @ 11:36 PM
Ignite Modification Date: 2026-01-09 @ 12:18 PM
Study NCT ID: NCT03144856
Status: UNKNOWN
Last Update Posted: 2017-05-09
First Post: 2017-05-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Apatinib as Second Line Therapy in Patients With Advanced Refractory Biliary Tract Cancers
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module